Acura Pharmaceuticals (ACUR - Get Report) is a specialty pharmaceutical company engaged in research, development and manufacture of product candidates providing abuse deterrent features and benefits utilizing its Aversion and Impede Technologies. This stock is trading up 11% at $3.66 in recent trading.
Today's Range: $3.43-$3.7152-Week Range: $2.28-$6.80 Volume: 37,000 Three-Month Average Volume: 108,748 From a technical standpoint, this stock is now approaching a major breakout if it can manage to move above both its 200-day moving average at $3.73 and its 50-day moving average of $3.90 on high volume. A high-volume move above those levels should set this stock up to challenge $4.20 to $5.49 in the near future. That $4.20 price point is the next significant overhead resistance level, so if that gets taken out with volume, look for a big run higher in the near future. >>13 Biotech Stocks Bought and Sold by Hedge Funds
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts